Come up with a name for your new list and we'll add to it:
Proclara Biosciences raised a round of funding on February 20, 2012. Investors include
The Michael J. Fox Foundation.
Proclara Biosciences, formerly NeuroPhage Pharmaceuticals, is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously ta…